PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments
PALATIN TECHNOLOGIES, INC. (PTN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments of $0 for the 12-month period ending 2012-06-30, per its 10-K filed 2012-09-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments · last filed 2012-09-10
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2012 was $0.00.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2011 was $0.00.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2010 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 12 month |
|---|---|---|
| 2012-06-30 | $0.00 10-K · filed 2012-09-10 | |
| 2011-06-30 | $0.00 10-K · filed 2012-09-10 | |
| 2011-05-11 | $0.00 10-K · filed 2012-09-10 | |
| 2011-03-01 | $0.00 10-K · filed 2012-09-10 | |
| 2010-06-30 | $0.00 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |